
Translocations
Gene Security Network (GSN) now offers the first widely available PGD test to simultaneously evaluate aneuploidy across all 24 chromosomes and inherited unbalanced chromosome rearrangements such as those arising from parental reciprocal translocations and inversions.
TECHNOLOGY
Parental Support technology provides the most comprehensive PGD for translocation and inversion carriers. Historically testing has been performed using florescent in-situ hybridization (FISH) technology to create telomeric probes for the relevant chromosomes. A significant shortcoming to this method is the inability to evaluate all other chromosomes simultaneously. This can lead to the transfer of an embryo that may be free of an unbalanced structural rearrangement, but fails to implant or miscarries due to sporadic whole chromosome aneuploidy.
Parental Support™ technology uses over 300,000 microarray measurements to evaluate aneuploidy across all 24 chromosomes in addition to detecting inherited unbalanced chromosome rearrangements. Results are returned the morning of Day 5 for Day 3 blastomere analysis, and in about one week for Day 5 trophectoderm analysis. Since balanced structural rearrangements are indistinguishable from normal chromosomes, results for both states are reported out as ‘normal’.
HOW DO I GET TESTING?
Testing for unbalanced chromosome arrangements requires prior approval from the GSN laboratory team. This review and approval process is performed at no cost. To begin this review process, please see the section “Steps to GSN Testing for Translocation, Inversions, and other Chromosome Rearrangements” above or contact us directly for more information.
BACKGROUND
Individuals carrying a balanced chromosome rearrangement are at increased risk to create eggs or sperm — and resulting embryos — with an unbalanced chromosome state. Pregnancies with unbalanced chromosome rearrangements are frequently lost in miscarriage, or can result in the birth of a baby with birth defects and mental retardation. In some couples the parental chromosome rearrangement may contribute to infertility due to failed implantation. Structural chromosome rearrangements are identified in approximately 3-5% of couples who have experienced recurrent pregnancy loss (RPL).
One treatment option for patients who carry structural chromosome rearrangements is to undergo in vitro fertilization (IVF) and PGD to identify embryos with normal or balanced chromosome complements. These embryos can then be selectively transferred to the patient. Couples with balanced rearrangements who undergo PGD have a significantly decreased risk of miscarriage and chromosomally abnormal liveborns.[ Lalioti MD Curr Opin Obstet Gynecol 2008, Lim CK, Fertil Steril 2008]
Find a list of GSN’s Partner IVF Clinics testing for Translocations nearest you.